Comprehensive Drug Collection Summary
========================================

Pipeline Drugs Found: 172
FDA Documents: 990
Clinical Trial Documents: 8130
Company Documents: 465
Clinical Trials (Extracted): 27
Total Documents: 9780
Success: True

Pipeline Drugs by Company:
==============================

Johnson & Johnson:
------------------
    1. Atezolizumab
    2. Bevacizumab
    3. Bleximenib
    4. Cetrelimab
    5. Codrituzumab
    6. Daratumumab
    7. Durvalumab
    8. Erdafitinib
    9. Genmab
   10. Guselkumab
   11. Ibrutinib
   12. Ipilimumab
   13. Lazertinib
   14. Mosunetuzumab
   15. Nipocalimab
   16. Niraparib
   17. Nivolumab
   18. Olaparib
   19. Palbociclib
   20. Pembrolizumab
   21. Polatuzumab
   22. Posdinemab
   23. Relatlimab
   24. Rg6810
   25. Rituximab
   26. Rucaparib
   27. Talquetamab
   28. Teclistamab
   29. Trastuzumab
   30. Ustekinumab
   31. abemaciclib
   32. alectinib
   33. atezolizumab
   34. avelumab
   35. bevacizumab
   36. blinatumomab
   37. cemiplimab
   38. ceritinib
   39. codrituzumab
   40. crizotinib
   41. dasatinib
   42. durvalumab
   43. elotuzumab
   44. glofitamab
   45. ipilimumab
   46. lorlatinib
   47. mosunetuzumab
   48. nemtabrutinib
   49. niraparib
   50. nivolumab
   51. olaparib
   52. palbociclib
   53. pembrolizumab
   54. polatuzumab
   55. relatlimab
   56. repotrectinib
   57. rg6810
   58. ribociclib
   59. rituximab
   60. rucaparib
   61. sacituzumab
   62. talazoparib
   63. trastuzumab

Pfizer:
-------
    1. Alectinib
    2. Cevostamab
    3. Glofitamab
    4. Pembrolizumab
    5. alectinib
    6. cevostamab
    7. glofitamab
    8. pembrolizumab

Merck & Co.:
------------
    1. Pembrolizumab

AbbVie:
-------
    1. Budigalimab
    2. Concept
    3. Elezanumab
    4. Epcoritamab
    5. Livmoniplimab
    6. Lutikizumab
    7. Mirvetuximab
    8. Pivekimab
    9. Ravagalimab
   10. Risankizumab
   11. Telisotuzumab
   12. Temab
   13. Upadacitinib

Sanofi:
-------
    1. Amlitelimab
    2. Frexalimab
    3. Itepekimab
    4. Name
Amlitelimab
    5. Name
Frexalimab
    6. Name
Itepekimab
    7. Name
Rilzabrutinib
    8. Name
Teplizumab
    9. Name
Tolebrutinib
   10. Rilzabrutinib
   11. Teplizumab
   12. Tolebrutinib

Bristol Myers Squibb:
---------------------
    1. Nivolumab

AstraZeneca:
------------
    1. Abemaciclib
    2. Anselamimab
    3. Bevacizumab
    4. Datopotamab
    5. Domvanalimab
    6. Gefurulimab
    7. Lenvatinib
    8. Monalizumab
    9. Obinutuzumab
   10. Oleclumab
   11. Osimertinib
   12. Palbociclib
   13. Pembrolizumab
   14. Tozorakimab
   15. Volrustomig + Lenvatinib
   16. abemaciclib
   17. bevacizumab
   18. olaparib
   19. palbociclib
   20. pembrolizumab

Eli Lilly:
----------
    1. Abemaciclib

GlaxoSmithKline (GSK):
----------------------
    1. Belantamab
    2. Cobolimab
    3. Depemokimab
    4. Dostarlimab
    5. Latozinemab
    6. Mepolizumab
    7. Momelotinib
    8. Niraparib
    9. niraparib

Regeneron Pharmaceuticals:
--------------------------
    1. Cemiplimab
    2. Dupilumab
    3. Fianlimab
    4. Garetosmab
    5. Linvoseltamab
    6. Mibavademab
    7. Odronextamab
    8. Pozelimab
    9. Sarilumab
   10. Trevogrumab
   11. Ubamatamab
   12. cemiplimab

BeiGene:
--------
    1. Blinatumomab
    2. Durvalamab
    3. Tarlatamab
    4. Tislelizumab
    5. Zanidatamab
    6. Zanubrutinib
    7. blinatumomab

FDA Drug Label API:
-------------------
    1. Denosumab
    2. Flammab
    3. Imatinib
    4. Infliximab
    5. Pertuzumab
    6. Recept

containing:
-----------
    1. atezolizumab
    2. blinatumomab

Pfizer Laboratories Div Pfizer Inc:
-----------------------------------
    1. Infliximab

Organon LLC:
------------
    1. Denosumab

GE Healthcare Inc.:
-------------------
    1. Recept

Janssen Biotech, Inc.:
----------------------
    1. Amivantamab
    2. Golimumab

Amgen, Inc:
-----------
    1. Blinatumomab
    2. Rituximab

Genentech, Inc.:
----------------
    1. Atezolizumab
    2. Pertuzumab
    3. Trastuzumab

Amneal Pharmaceuticals LLC:
---------------------------
    1. Bevacizumab

Mylan Institutional Inc:
------------------------
    1. Imatinib

KLEIN TOOLS, INC.:
------------------
    1. Flammab

AstraZeneca Pharmaceuticals LP:
-------------------------------
    1. Acalabrutinib

Regeneron Pharmaceuticals, Inc.:
--------------------------------
    1. Aflibercept
    2. Cemiplimab

GlaxoSmithKline LLC:
--------------------
    1. Belimumab


Summary by Company:
====================
  Johnson & Johnson: 63 drugs
  Pfizer: 8 drugs
  Roche/Genentech: 0 drugs
  Novartis: 0 drugs
  Merck & Co.: 1 drugs
  AbbVie: 13 drugs
  Sanofi: 12 drugs
  Bristol Myers Squibb: 1 drugs
  AstraZeneca: 20 drugs
  Eli Lilly: 1 drugs
  GlaxoSmithKline (GSK): 9 drugs
  Bayer: 0 drugs
  Amgen: 0 drugs
  Takeda Pharmaceutical: 0 drugs
  Boehringer Ingelheim: 0 drugs
  Moderna: 0 drugs
  Regeneron Pharmaceuticals: 12 drugs
  CSL: 0 drugs
  Biogen: 0 drugs
  Vertex Pharmaceuticals: 0 drugs
  Gilead Sciences: 0 drugs
  Seagen: 0 drugs
  BeiGene: 7 drugs
  Incyte: 0 drugs
  Alnylam Pharmaceuticals: 0 drugs
  Daiichi Sankyo: 0 drugs
  Merck KGaA: 0 drugs
  BioNTech: 0 drugs
  Astellas Pharma: 0 drugs
  Illumina: 0 drugs
  FDA Drug Label API: 6 drugs
  half of all patients treated by causing: 0 drugs
  midnight: 0 drugs
  Hello Bello: 0 drugs
  Do not administer in the same intravenous line concurrent with the other medicinal: 0 drugs
  Major Pharmaceuticals: 0 drugs
  Preparation and Administration Parenteral drug: 0 drugs
  used under trademark license: 0 drugs
  the symptoms of hypocalcemia and the importance of maintaining serum calcium levels with adequate calcium and activated vitamin: 0 drugs
  AqVida GmbH: 0 drugs
  Dr. Reddy's Laboratories Limited: 0 drugs
  or patients taking other medicinal: 0 drugs
  the concomitant use of SIMPONI ARIA and these biologic: 0 drugs
  Redpharm Drug: 0 drugs
  driving: 0 drugs
  Zhuhai Beihai Biotech Co., Ltd.: 0 drugs
  containing: 2 drugs
  Waylis Therapeutics LLC: 0 drugs
  Coupler LLC: 0 drugs
  sanofi-aventis: 0 drugs
  Avyxa Pharma, LLC: 0 drugs
  BPI Labs LLC: 0 drugs
  Eugia US LLC: 0 drugs
  Teyro Labs Private Limited: 0 drugs
  Apotex Corp.: 0 drugs
  ANI Pharmaceuticals, Inc.: 0 drugs
  Marlex Pharmaceuticals, Inc.: 0 drugs
  Janssen Biotech, Inc: 0 drugs
  KATHLEEN P. HUTTON, M.D., INC. A PROFESSIONAL CORPORATION: 0 drugs
  Aurobindo Pharma Limited: 0 drugs
  Preferred Pharmaceuticals Inc.: 0 drugs
  Pfizer Laboratories Div Pfizer Inc: 1 drugs
  GLENMARK PHARMACEUTICALS INC., USA: 0 drugs
  Preferred Pharmaceuticals, Inc.: 0 drugs
  Organon LLC: 1 drugs
  GE Healthcare Inc.: 1 drugs
  PHOENIX RX LLC: 0 drugs
  Janssen Biotech, Inc.: 2 drugs
  Amgen, Inc: 2 drugs
  Daiichi Sankyo Inc.: 0 drugs
  Genentech, Inc.: 3 drugs
  Cephalon, Inc.: 0 drugs
  Accord BioPharma Inc.: 0 drugs
  Biocon Biologics Inc.: 0 drugs
  CELLTRION USA, Inc.: 0 drugs
  Bio-Thera Solutions, Ltd.: 0 drugs
  Amneal Pharmaceuticals LLC: 1 drugs
  REMEDYREPACK INC.: 0 drugs
  Quallent Pharmaceuticals Health LLC: 0 drugs
  Ascend Laboratories, LLC: 0 drugs
  Aphena Pharma Solutions - Tennessee, LLC: 0 drugs
  Bryant Ranch Prepack: 0 drugs
  PD-Rx Pharmaceuticals, Inc.: 0 drugs
  A-S Medication Solutions: 0 drugs
  RedPharm Drug, Inc.: 0 drugs
  Cardinal Health 107, LLC: 0 drugs
  ScieGen Pharmaceuticals, Inc.: 0 drugs
  NorthStar RxLLC: 0 drugs
  Mylan Institutional Inc: 1 drugs
  KLEIN TOOLS, INC.: 1 drugs
  ProPharma Distribution: 0 drugs
  AstraZeneca Pharmaceuticals LP: 1 drugs
  sanofi-aventis U.S. LLC: 0 drugs
  Valorum Biologics Inc: 0 drugs
  Regeneron Pharmaceuticals, Inc: 0 drugs
  Regeneron Pharmaceuticals, Inc.: 2 drugs
  Autolus Inc.: 0 drugs
  Kite Pharma, Inc.: 0 drugs
  Adaptimmune LLC: 0 drugs
  GlaxoSmithKline LLC: 1 drugs
  Accord Healthcare, Inc.: 0 drugs
  Hospira, Inc.: 0 drugs
  Gland Pharma Limited: 0 drugs
  Henry Schein, Inc.: 0 drugs